Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concentration/meditation to limit inflammation in human endotoxemia
2012-004622-14Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2012
- Countries
- 1
01
Overview
Phase 2, randomised trial of lipopolysaccharide endotoxin in immunity and inflammation (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Circulating TNF-α after LPS administration. Started Oct 2012; status: completed.
02
Drugs
lipopolysaccharide endotoxin
03
Conditions
immunity and inflammation
Beyond the preview
Go deeper on 2012-004622-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004622-14.